86857807 - V VIVA

Information

• Trademark
• 86857807

• Source

• Serial Number

  86857807

• International Classifications

  • 3 - Bleaching preparations and other substances for laundry use
  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  December 26, 2015
  9 years ago

• Transaction Date

  March 10, 2021
  3 years ago

• Status Date

  March 10, 2021
  3 years ago

• Location Date

  March 10, 2021
  3 years ago

• Status Code

  602

• Current Location

  TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  REGAN, JOHN B

• Attorney Docket Number

  2898-00890

  Attorney Name

  Gina Lupino

  Law Office Assigned Location Code

  M40

• Owners

  • Viva Pharmaceutical Inc.

Case File Statements

• CC0000: Color is not claimed as a feature of the mark.
• DM0000: The mark consists of "VIVA" & design.
• GS0031: Skin cleansing lotions; skin clarifiers and skin masks
• GS0051: Skin emollient preparations, hair care preparations and skin care preparations, namely, dermatologicals, antibiotic tissue healants, anti-inflammatory and antibacterial ointments, corticosteroid ointments and creams, antiinfective ointments and creams, scabicides; anti-viral ointments and creams; full line of pharmaceutical preparations and substances, namely, pharmaceutical preparations and substances for the treatment, alleviation and/or prevention of gastro-intestinal disorders, disorders of the central nervous system, disorders of the respiratory system, heart conditions and other disorders of the cardiovascular system, and migraines and other forms of headache; analgesics; antivirals; anaesthetics; anti-infectives; anti-inflammatories; antibiotics; antidepressants; broncho-dilators; anti-cancer preparations; medicated lotions for the skin and hair; decongestants and anti-histamines; muscle relaxants; anti-emetics; immunosuppressive agents; antispasmodic agents, antiepileptic agents; cardiotonics; scabicides; anti-malarials; cough suppressants; cough and cold preparations; expectorants; anti-leukemic agents; anti-arrhythmics; dermatologicals; tissue healants; lung surfactants; vasopressors; ophthalmic and optic agents; antitumour agents; antidotes to digitalis poisoning; preparations for treatment of digoxin and digitoxin intoxication; antineoplastic agents; antiprotozoal agents; nondepolarizing skeletal neuromuscular blocking agents; preparations for treatment of gout; xanthine oxidase inhibitors; preparations for cessation of smoking; preparations for treatment of Parkinson's disease; preparations for treatment of hypothyroidism; full line of nutraceutical preparations and substances, namely, extracts or isolates from plant, alga, fungus, non-human animal material, bacterium (including spirulina and non-living, e.g. tyndallized bacteria), namely, enzymes, vitamins, minerals, amino acids, essential fatty acids, synthetic duplicates, probiotics, homeopathic medicines; probiotics, namely, acidophilus, bifidobacterium and lactobacillus; vitamin compounds, namely, vitamin supplements, vitamins, multi-vitamins, vitamin compounds with minerals, vitamin compounds with iron; mineral preparations, namely, minerals; nutritional, dietary and herbal supplements and herbal preparations, namely, semen platycladi, radix polygalae, indole-3-carbionol, 5-hydroxy-L-tryptophan, echinacea, bilberry, cascara sagrada, celery seed, cranberry, nettle root, uva ursi, dandelion root, devil's claw, feverfew, ginger root, ginkgo biloba, grapeseed, resveratrol, citrus bioflavonoids, green tea, hawthorn, horse chestnut, milk thistle, olive leaf, panax ginseng, saw palmetto, siberian ginseng, silica, St. John's Wort, valerian, lutein, zeaxanthin, cayenne, hawaiian spirulina, swedish bitters; fatty supplements, namely, flax seed oil and fish derived oils; glucosamine, chondroitin, methyl-sulfonyl-methane, whey, creatine; herbal products, namely, herbals; standardized herbal extracts, namely, semen platycladi, radix polygalae, echinacea, bilberry, cascara sagrada, celery seed, cranberry, nettle root, uva ursi, dandelion root, devil's claw, feverfew, ginger root, ginkgo biloba, grapeseed, green tea, hawthorn, horse chestnut, milk thistle, olive leaf, panax ginseng, saw palmetto, siberian ginseng, silica, St. John's Wort, valerian, lutein, zeaxanthin, cayenne, hawaiian spirulina, swedish bitters; nutraceuticals, namely, dietary supplements and herbal products, namely, folic acid, lutein, zeaxanthin, lycopene, acidophilus, bee pollen, beta-carotene, bromelain, choline, flavonoids, grape seed extract, kelp, lecithin, lipoic acid, mushroom extracts, SAM-e, crustacean exoskeleton, soy protein, spirulina; amino acid compounds, namely, NAC (n-acetyl cysteine) and L-glutamine; sports nutrition products, namely, whey proteins and creatines; antioxidants, namely, vitamins C and E, vitamin A, beta-carotene, selenium and carotenoids; cosmeceuticals, namely, medicinal herbal creams, lotions and oils for treatment of skin damage and repair; food products, namely, herbs, greens, dehydrated foods derived from plants, namely, vegetable and fruit powder, vegetable protein and greens, natural flavors derived from fruits, dietary fiber; evening primrose oil, salmon oil, whey, creatine; nutritional products and natural health products, namely, carotenoids, enzymes, alfalfa leaf, conjugated linoleic acid, apple cider vinegar, fenugreek seed, coenzyme Q10, alpha lipoic acid, pine bark extract, crustacean exoskeleton, garlic, kelp, pectin, policosanol, flaxseed oil, pumpkin seed oil, borage oil, perilla seed oil, salmon oil, evening primrose oil, tuna oil, thyme oil, peppermint oil complex, lecithin, phosphatidyl choline, soya lecithin granules, phosphatidyl serine, bee pollen, bee propolis, royal jelly, soy isoflavones complex, chasteberry, echinacea

Case File Event Statements

• 3/10/2021 - 3 years ago

  57 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2

• 3/10/2021 - 3 years ago

  56 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2

• 8/20/2020 - 4 years ago

  55 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 8/20/2020 - 4 years ago

  54 - NON-FINAL ACTION E-MAILED Type: GNRT

• 8/20/2020 - 4 years ago

  53 - NON-FINAL ACTION WRITTEN Type: CNRT

• 7/28/2020 - 4 years ago

  52 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/28/2020 - 4 years ago

  51 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/21/2020 - 4 years ago

  50 - ASSIGNED TO LIE Type: ALIE

• 7/14/2020 - 4 years ago

  49 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 1/17/2020 - 4 years ago

  48 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 1/17/2020 - 4 years ago

  47 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 1/17/2020 - 4 years ago

  46 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 1/6/2020 - 5 years ago

  45 - LIE CHECKED SUSP - TO ATTY FOR ACTION Type: RCCK

• 8/1/2019 - 5 years ago

  44 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 8/1/2019 - 5 years ago

  43 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 6/20/2019 - 5 years ago

  42 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 6/20/2019 - 5 years ago

  41 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 6/20/2019 - 5 years ago

  40 - SUSPENSION LETTER WRITTEN Type: CNSL

• 6/13/2019 - 5 years ago

  39 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/13/2019 - 5 years ago

  38 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/11/2019 - 5 years ago

  37 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 12/14/2018 - 6 years ago

  36 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 12/14/2018 - 6 years ago

  35 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 12/14/2018 - 6 years ago

  34 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 11/29/2018 - 6 years ago

  33 - LIE CHECKED SUSP - TO ATTY FOR ACTION Type: RCCK

• 5/29/2018 - 6 years ago

  32 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 5/29/2018 - 6 years ago

  31 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 5/29/2018 - 6 years ago

  30 - SUSPENSION LETTER WRITTEN Type: CNSL

• 5/8/2018 - 6 years ago

  29 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/8/2018 - 6 years ago

  28 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/7/2018 - 6 years ago

  27 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 12/7/2017 - 7 years ago

  26 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 12/7/2017 - 7 years ago

  25 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 12/7/2017 - 7 years ago

  24 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 11/17/2017 - 7 years ago

  23 - LIE CHECKED SUSP - TO ATTY FOR ACTION Type: RCCK

• 5/3/2017 - 7 years ago

  22 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 5/3/2017 - 7 years ago

  21 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 5/3/2017 - 7 years ago

  20 - SUSPENSION LETTER WRITTEN Type: CNSL

• 5/1/2017 - 7 years ago

  19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/1/2017 - 7 years ago

  18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/28/2017 - 7 years ago

  17 - ASSIGNED TO LIE Type: ALIE

• 4/20/2017 - 7 years ago

  16 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 4/20/2017 - 7 years ago

  15 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 10/27/2016 - 8 years ago

  14 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 10/27/2016 - 8 years ago

  13 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 10/27/2016 - 8 years ago

  12 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 10/21/2016 - 8 years ago

  11 - LIE CHECKED SUSP - TO ATTY FOR ACTION Type: RCCK

• 4/19/2016 - 8 years ago

  10 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 4/19/2016 - 8 years ago

  9 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 4/19/2016 - 8 years ago

  8 - SUSPENSION LETTER WRITTEN Type: CNSL

• 4/12/2016 - 8 years ago

  7 - ASSIGNED TO EXAMINER Type: DOCK

• 1/29/2016 - 8 years ago

  6 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX

• 1/21/2016 - 8 years ago

  5 - ASSIGNED TO LIE Type: ALIE

• 1/7/2016 - 9 years ago

  4 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 1/6/2016 - 9 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 1/5/2016 - 9 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 12/30/2015 - 9 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP